Abstract 2735: Development of a novel, fully human anti-CD19 chimeric antigen receptor for <i>in vivo</i> delivery via CD8-targeted fusosome
Jeremy M. Kinder(Sana Biotechnology (United States)), Aaron E. Foster(Medpace (United States)), Neal Van Hoeven(Sana Biotechnology (United States)), Garrett Zipp(Sana Biotechnology (United States)), Kutlu G. Elpek(Sana Biotechnology (United States)), Aaron Lampano(Fred Hutch Cancer Center), Adam Johnson(Sana Biotechnology (United States)), Vandana Chaturvedi(Sana Biotechnology (United States)), Christie Ciarlo(Altius Institute for Biomedical Sciences), Chanel Athena Estrada(Sana Biotechnology (United States)), Terry J. Fry(University of Colorado Anschutz Medical Campus)
Cited by 0
Related Papers
A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission
|Science|2007|582
Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air
|Proceedings of the National Academy of Sciences|2009|224
De novo design of protein logic gates
|Science|2020|224
Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility
|Proceedings of the National Academy of Sciences|2008|198
The <i>Mx1</i> Gene Protects Mice against the Pandemic 1918 and Highly Lethal Human H5N1 Influenza Viruses
|Journal of Virology|2007|182